Search

Your search keyword '"Langebeek N"' showing total 86 results

Search Constraints

Start Over You searched for: Author "Langebeek N" Remove constraint Author: "Langebeek N"
86 results on '"Langebeek N"'

Search Results

1. De‐simplifying antiretroviral therapy from a single‐tablet to a two‐tablet regimen: Acceptance, patient‐reported outcomes, and cost savings in a multicentre study

2. HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study

Catalog

Books, media, physical & digital resources

3. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

4. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

5. Management of drug interactions with direct‐acting antivirals in Dutch HIV/hepatitis C virus‐coinfected patients: adequate but not perfect

6. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

7. A highly virulent variant of HIV-1 circulating in the Netherlands

8. Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process

9. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

10. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

11. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

12. A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study

14. HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study

15. Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM

16. Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV

17. Does a simplified regimen give a better adherence, treatment satisfaction, and quality of life?

18. High treatment uptake in human immunodeficiency virus/ hepatitis C virus-coinfected patients after unrestricted access to direct-acting antivirals in the Netherlands

19. Treatment adherence, health related quality of life and aging in HIV-1 infected patients

20. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

21. Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe

22. Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

23. Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996-2014: results from a national observational cohort

24. Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

25. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

26. Primary resistance to integrase strand-transfer inhibitors in Europe

27. Primary resistance to integrase strand-transfer inhibitors in Europe

28. Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe

29. Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe

30. Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

31. Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

32. Limited cross-border infections in patients newly diagnosed with HIV in Europe

33. Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

34. A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy : Final 96-week results from the FREE study

35. A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: Final 96-week results from the FREE study

36. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

39. A randomized controlled trial of single‐class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96‐week results from the FREE study

40. Abacavir/lamivudine/zidovudine maintenance after standard induction in antiretroviral therapy-naive patients: FREE randomized trial interim results.

42. Over openen en sluiten van potjes en perspectieven

43. Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring.

44. Abacavir/lamivudine/zidovudine maintenance after standard induction in antiretroviral therapy-naïve patients: free randomized trial interim results.

45. Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination.

46. Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process.

47. Impact of comorbidity and ageing on health-related quality of life in HIV-positive and HIV-negative individuals.

49. Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

50. Electronic medication monitoring-informed counseling to improve adherence to combination anti-retroviral therapy and virologic treatment outcomes: a meta-analysis.